Metraipolis › archive › dc_62e543725381

COVID-19 Microangiopathy: Insights into plasma exchange as a therapeutic strategy — Europe PMC PMID:40850218

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40850218
DOI
10.1016/j.htct.2025.103963
License (as archived)
solo-consultazione
Archived
2026-11-10T10:14:39.334Z
SHA-256 of the archived text
91ad743c93fdacc1968358a7a28cc32baf1e1c18a145d38d825360169934648c
Stable URL of this page
https://metraipolis.com/documento/dc_62e543725381

How to cite

COVID-19 Microangiopathy: Insights into plasma exchange as a therapeutic strategy — Europe PMC PMID:40850218 — Europe PMC (en), https://europepmc.org/article/MED/40850218 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_62e543725381 (Metraipolis archive dc_62e543725381, sha256 91ad743c93fdacc1968358a7a28cc32baf1e1c18a145d38d825360169934648c)
BibTeX
@misc{dc62e543725381,
  title = {COVID-19 Microangiopathy: Insights into plasma exchange as a therapeutic strategy — Europe PMC PMID:40850218},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40850218},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_62e543725381; sha256 91ad743c93fdacc1968358a7a28cc32baf1e1c18a145d38d825360169934648c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40850218. Agents can read the archived copy with the MCP tool read_document.